Dianthus Therapeutics Inc <DNTH.O>: Citigroup initiates coverage with buy rating; target price $156
DNTH•Related News
RTX Pratt & Whitney invests $25 million to expand Poland precision parts plant
RTX•
Instinct Bio teams up with Invitrx to develop GENRÊVER cosmetic product line in US
BIOT•
Victoria's Secret & Co.: Barclays cuts target price to $106 from $108
VSCO•
Bilibili to raise $700 million in convertible notes, Tencent to subscribe for $200 million
BILI•
MORNING BID AMERICAS-Bonds' reality check
SPY•